semaglutide and the heart Potential action mechanisms of in phenotype of STEP-HFpEF Trial

Women are more likely than men to say they at least sometimes feel pressure to conform to body size or weight standards (60% vs

Whether through dietary choices, lifestyle modifications, or targeted supplementation, we have the power to enhance our glutathione status

Researchers face the ongoing need to optimize treatments that effectively address both diabetes and obesity while mitigating adverse effects in diverse populations

Hypoglycaemia: Risk is low with GLP-1 monotherapy but increases when combined with insulin or sulphonylureas

FR reports equity from Carta Healthcare and HealthPals, and consulting fees from HealthPals, Novartis, NovoNordisk, Esperion Therapeutics, Movano Health, Kento Health, Inclusive Health, Edwards, Arrowhead Pharmaceuticals, and HeartFlow outside the submitted work